Rheumatology

Latest News

AI generated syringe and money | Image credit: Luluraschi - stock.adobe.com
Celltrion Sets Sights on 2030 With Expanded Biosimilar Portfolio, Market Reach

November 6th 2024

Celltrion plans to commercialize 22 biosimilars by 2030, expanding its global presence with robust sales growth driven by core biosimilars and new launches like subcutaneous infliximab.

EOP thumbnail
Eye on Pharma: Henlius, Organon Updates; Meitheal Portfolio Expansion; Celltrion Zymfentra Data

November 5th 2024

AI generated health care business deal | Image credit: Daniel - stock.adobe.com
How Policy Reforms in PBM Systems Could Change the Adalimumab Market

October 28th 2024

psoriasis | Image credit: SergeVo - stock.adobe.com
Phase 3 Study Reports Similar Efficacy Between SB17, Stelara in Psoriasis

October 19th 2024

Eye on pharma banner
Eye on Pharma: Aflibercept Legal Drama; PBM, Humira Biosimilars; Denosumab Regulatory Review

October 15th 2024

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcas
CFB podcast banner
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.